FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Jefferies analyst Sean Dodge lowered the price target on Evolent Health (NYSE: EVH) to $23.00 (from $30.00) while maintaining a Buy rating.
... MoreOppenheimer analyst Mohan Naidu lowered the price target on Evolent Health (NYSE: EVH) to $21.00 (from $31.00) while maintaining a Outperform rating following the company's 4Q earnings report. EVH reported revenue of $193M vs. consensus of $189M. Adjusted EPS was ($0.07) vs. consensus's ($0.04).
For CY19, EVH... More

